Human papillomavirus and human immunodeficiency virus infections: Relation with cervical dysplasia-neoplasia in African women

International Journal of Cancer

Volumn 76, Issue 4, 1998, Pages 480-486

  La Ruche, Guy ^a   You, Bruno ^b   Mensah Ado, Isabelle ^c   Bergeron, Christine ^d   Montcho, Crépin ^b   Ramon, Rosa ^a   Touré Coulibaly, Karidiata ^b   Welffens Ekra, Christiane ^e   Dabis, François ^f   Orth, Gérard ^g  

^a Prog Natl de Lutte contre le SIDA   (Côte d’Ivoire)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^c Dept d'Anesthesie Reanimation   (Côte d’Ivoire)

^d LABORATOIRE CERBA   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^f INSERM   (France)

^g INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

AFRICA; AFRICA SOUTH OF THE SAHARA; BIOLOGY; CANCER; CASE CONTROL STUDIES; CERVICAL CANCER; CERVICAL EFFECTS; CERVIX; DEVELOPING COUNTRIES; DISEASES; EXAMINATIONS AND DIAGNOSES; FRENCH SPEAKING AFRICA; GENITALIA; GENITALIA, FEMALE; HIV INFECTIONS--WOMEN; HPV; IVORY COAST; NEOPLASMS; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS--WOMEN; SCREENING--WOMEN; STUDIES; UROGENITAL SYSTEM; UTERUS; VIRAL DISEASES; WESTERN AFRICA; WOMEN;

ADULT; AFRICA; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; UTERINE CERVICAL NEOPLASMS;

EID: 0031980865     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980518)76:4<480::AID-IJC6>3.0.CO;2-N     Document Type: Article

References (44)

1. ADAMS, V., MOLL, C., SCHMID, M., RODRIGUES, C., MOOS, R. and BRINER, J., Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomalion. J. med. Virol. 48, 161-170 (1996).
2. ARMITAGE, P, and BERRY, G., Statistical methods in epidemiology. Attributable risk. In: P. Armitage and G. Berry (eds.), Statistical methods in medical research, pp. 469-472. Blackwell, Oxford (1987).
3. BARNUM, H. and GREENBERG, E.R., Cancers. In: D.T. Jamison and W.H. Mosley (eds.), Diseuses control priorities in developing countries, pp. 529-559, Oxford University Press for the World Bank, New York (1993).
4. BASSETT, M., CHOKUNONGA, E., MAUCHAZA, B., LEVY, L., FERLAY, J. and PARKIN, D., Cancer in the African population of Harare, Zimbabwe. 1990-1992. Int. J. Cancer, 63, 29-36 (1995).
5. BERGERON, C., BARRASSO, R., BEAUDENON, S., FLAMANT, P., CROISSANT, O. and ORTH, G., Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Amer. J. surg. Pathol., 16, 641-649 (1992).
6. BERNARD, H.U., CHAN, S.Y., MANOS, M.M., ONG, C.K., VILLA, L.L., DELIUS, H., PEYTON, C.L., BAUER, H.M. and WHEELER, C.M., Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. infect. Dis., 170, 1077-1085 (1994).
7. BOCCALON, M., TIRELLI, U., SOPRACORDEVOLE, F. and VACCHER, E., Intra-epithelial and invasive cervical neoplasia during HIV infection. Europ. J. Cancer, 32A, 2212-2217 (1996).
8. BOSCH, F.X., MASOS, M.M., MUÑOZ, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R., SHAH, K.V. and International Biological Study on Cervical Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. nat. Cancer Inst., 87, 796-802 (1995).
9. BRAUN, L., Role of human immunodeficiency virus infection in the pathogenosis of human papillomavirus-associated cervical neoplasia. Amer. J. Pathol., 144, 209-214 (1994).
10. BRINTON, L.A., HAMMAN, R.F. HUGGINS, G.R., LEHMAN, H.F. LEVINE, R.S. and MALLIN, K., Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J. nat. Cancer Inst., 79, 23-30 (1987).
11. CENTERS FOR DISEASE CONTROL, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. J. Amer. med. Ass., 269, 729-730 (1993).
12. CHABAUD, M., LE CANN, P., MAYELO, V., LEBOULLEUX, D., DIALLO, A., ENOGAT, N., AFOUTOU, J., ANTHONIOZ, P., COLL-SECK, A. and COURSAGET, P., Detection by PCR of human papillomavirus genotypes in cervical lesions of Senegalese women. J. med. Virol., 49, 259-263 (1996).
13. CHOPRA, K.F. and TYRING, S.K., The impact of the human immunodeficiency virus on the human papillomavirus epidemic. Arch. Dermatol., 133, 629-633 (1997).
14. COLL-SECK, A., FAYE, M.A., CRITCHLOW, C.W., MBAY, A.D., KUYPERS, J., WOTO-GAYE, G., LANGLEY, C., DE, B.E., HOLMES, K.K. and KIVIAT, N.B., Cervical intruepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or H1V-2 or seronegative for HIV. Int. J. STD. AIDS, 5, 189-193 (1994).
15. DE COCK, K.M., BARRERE, B., DIABY, L. LAFONTAINE, M.F., GNAORE, E., PORTER, A., PANTOBE, D., LAFONTANT, G.C., DAGO-AKRIBI, A., ETTE, M., ODEHOURI, K. and HEYWARD, W.L., AIDS - the leading cause of death in the West African city of Abidjan, Ivory Coast. Science, 249, 793-796 (1990).
16. HELLBERG, D. and NILSSON, S., 20-year experience of follow-up of the abnormal smear with colposcopy and histology and treatment by conization or cryosurgery. Gynecol. Oncol., 38, 166-169 (1990).
17. HERRERO, R., BRINTON, L.A., REEVES, W.C., BRENES, M.M., DE BRITTON, R.C. and TENORIO, F., Injectable contraceptives and risk of invasive cervical cancer: evidence of an association. Int. J. Cancer. 46, 5-7 (1990a).
18. HERRERO, R., BRINTON, L.A., REEVES, W.C., BRENES, M.M., TENORIO, F., DE BRITTON, R.C., GAITAN, E., GARCIA, M. and RAWLS, W.E., Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer, 65, 380-386 (1990b).
19. Ho, G.Y.F., BURK, R.D., FLEMING, I. and KLEIN, R.S., Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int. J. Cancer. 56, 788-792 (1994).
20. JACOBS, M.V., DE RODA HUSMAN, A.M., VAN DEN BRULE, A.J.C., SNIJDERS, P.J.F., MEIJEK, C.J.L.M. and WALBOOMERS, J.M.M., Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol., 33, 901-905 (1995).
21. KLEIN, R.S., HO, G.Y.F., VERMUND, S.H., FLEMING, I. and BURK, R.D., Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J. infect. Dis., 170, 1404-1409 (1994).
22. KOULIBALY, M., KABBA, I.S., CISSÉ, A., DIALLO, S.B., DIALLO, M.B., KEITA, N., CAMARA, N.D., DIALLO, M.S., SYLLA, B.S. and PARKIN, D.M., Cancer incidence in Conakry, Guinea: first results from the cancer registry 1992-1995. Int. J. Cancer. 70, 39-45 (1997).
23. LA RUCHE, G., WELFFENS-EKRA, C., RAMON, R., MENSAH-ADO, I., TOURÉ-COULIBALY, K., ANOH, S. and COULIBALY, I., Cervical intraepithelial neoplasia and invasive cervical cancer in relation to HIV and immunosuppression, XIth International Conference on AIDS, Vancouver (1996).
24. LAGA, M., ICENOGLE, J.P., MARSELLA, R., MANOKA, A.T., NZILA, N., RYDER, R.W., VERMUND, S.H., HEYWARD, W.L., NELSON, A. and REEVES, W.C., Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int. J. Cancer, 50, 45-48 (1992).
25. LUNGU, O., SUN, X.W., FELIX, J., RICHARD, R.M., SILVERSTEIN, S. and WRIGHT, T.C., Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. J. amer. med. Ass., 267, 2493-2496 (1992).
26. MAGGWA, B.N., HUNTER, D.J., MBUGUA, S., TUKEI, P. and MATI, J.K., The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya. AIDS, 7, 733-738 (1993).
27. MAIMAN, M., FRUCHTER, R.G., CLARK, M., ARRASTIA, C.D., MATTHEWS, R. and GATES, E.J., Cervical cancer as an AIDS-defining illness. Obstet. Gynecol., 89, 76-80 (1997).
28. MANDELBLATT, J.S., FAHS, M., GARIBALDI, K., SENIE, R.T. and PETERSON, H.B., Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions. AIDS, 6, 173-178 (1992).
29. MANOS, M.M., TING, Y., WRIGHT, D.K., LEWIS, A.J., BROKER, T.R. and WOLINSKY, S.M., Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7, 209-214 (1989).
30. NATIONAL CANCER INSTITUTE WORKSHOP, The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses. J. amer. med. Ass., 262, 931-934 (1989).
31. NATIONAL CANCER INSTITUTE WORKSHOP, The Bethesda system for reporting cervical/vaginal cytologic diagnoses. Acta Cytol., 37, 115-124 (1993).
32. PARKIN, D.M., LÄÄRÄ, E. and MUIR, C.S., Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41, 184-197 (1988).
33. PARKIN, D.M., PISANI, P. and FERLAY, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer. 54, 594-606 (1993).
34. RABKIN, C.S., BIGGAR, R.J., BAPTISTE, M.S., ABE, T., KOHLER, B.A. and NASCA, P.C., Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int. J. Cancer. 55, 208-212 (1993).
35. ROGO, K.O., EVANDER, M., BJERSING, L., STENDAL., U. and WADELL, G., Double infection in African cervical cancer detected by polymerase chain reaction. Anticancer Res., 11, 169-174 (1991).
36. ROGO, K.O. and KAVOO-LINGE, Human immunodeficiency virus seroprevalence among cervical cancer patients. Gynecol. Oncol., 37, 87-92 (1990).
37. SITAS, F. BEZWODA, W.R., LEVIN, V., RUFF P., KEW, M.C., HALE, M.J., CARRARA, H., BERAL, V. FLEMING, G., ODES, R. and WEAVING, A., Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Brit. J. Cancer, 75, 1704-1707 (1997).
38. SUN, X.W., ELLERBROCK, T.V., LUNGU, O., CHIASSON, M.A., BUSH, T.J. and WRIGHT, T.C., Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet. Gynecol., 85, 680-686 (1995).
39. TER MEULEN, J., EBERHARDT, H.C., LUANDE, J., MGAYA, H.N., CHANG-CLAUDE, J., MTIRO, H., MHINA, M., KASHAIJA, P., OCKERT, S., YU, X., GISSMANN, L. and PAWLITA, M., Human papillomavirus (HPV) infection. HIV infection and cervical cancer in Tanzania. East Africa. Int. J. Cancer, 51, 515-521 (1992).
40. VERMUND, S.H., KELLKY, K.F., KLEIN, R.S., FEINGOLD, A.R., SCHREIBER, K., MUNK, G. and BURK, R.D., High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Amer. J. Obstet. Gynecol., 165, 392-400 (1991).
41. VERNON, S.D., HART, C.E., REEVES, W.C. and ICENOGLE, J.P., The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription, Virus Res., 27, 133-145 (1993).
42. WILLIAMS, A.B., DARRAGH, T.M., VRANIZAN, K., OCHIA, C., MOSS, A.R. and PALBFSKY, J.M., Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet. Gynecol., 83, 205-211 (1994).
43. WILLIAMS, M.A., KENYA, P.R., MATI, J.K.G. and THOMAS, D.B., Risk factors for invasive cervical cancer in Kenyan women. Int. J. Epidemiol., 23, 906-912 (1994).
44. WILLIAMSON, A.L., BRINK, N.S., DEHAECK, C.M.C., OVENS, S., SOETERS, R. and RYBICKI, E.P., Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town. J. med. Virol., 43, 231-237 (1994).